Kristen L Jablonski1, Jelena Klawitter2, Michel Chonchol3, Candace J Bassett4, Matthew L Racine4, Douglas R Seals4. 1. Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado; and Division of Renal Diseases and Hypertension and Kristen.Nowak@ucdenver.edu. 2. Division of Renal Diseases and Hypertension and Department of Anesthesiology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado. 3. Division of Renal Diseases and Hypertension and. 4. Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado; and.
Abstract
BACKGROUND AND OBJECTIVES: Metabolomics is a relatively new field of "-omics" research, focusing on high-throughput identification of small molecular weight metabolites. Diet has both acute and chronic effects on metabolic profiles; however, alterations in response to dietary sodium restriction (DSR) are completely unknown. The goal of this study was to explore changes in urine metabolites in response to DSR, as well as their association with previously reported improvements in vascular function with DSR. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using stored urine samples from a 10-week randomized placebo-controlled crossover study of DSR in 17 middle-aged/older adults (six men and 11 women; mean age 62±8 years) who had moderately elevated systolic BP (130-159 mmHg) and were otherwise healthy, a liquid chromatography/mass spectrometry-based analysis of 289 metabolites was performed. This study identified metabolites that were significantly altered between the typical (153±29 mmol/d) and low (70±29 mmol/d) sodium conditions, as well as their baseline (typical sodium) association with responsiveness to previously reported improvements in vascular endothelial function (brachial artery flow-mediated dilation) and large elastic artery stiffness (aortic pulse wave velocity). RESULTS: Of the 289 metabolites surveyed, 10 were significantly altered (nine were upregulated and one was downregulated) during the low sodium condition, and eight of these exceeded our prespecified clinically significant threshold of a >40% change. These metabolites were involved in biologic pathways broadly related to cardiovascular risk, nitric oxide production, oxidative stress, osmotic regulation, and metabolism. One metabolite, serine, was independently (positively) associated with previously reported improvements in the primary vascular outcome of brachial artery flow-mediated dilation. CONCLUSIONS: This proof-of-concept study provides the first evidence that DSR is a stimulus that induces significant changes in urinary metabolomic profiles. Moreover, serine was independently associated with corresponding changes in vascular endothelial function after DSR. Larger follow-up studies will be required to confirm and further elucidate the metabolic pathways that are altered in response to DSR.
RCT Entities:
BACKGROUND AND OBJECTIVES: Metabolomics is a relatively new field of "-omics" research, focusing on high-throughput identification of small molecular weight metabolites. Diet has both acute and chronic effects on metabolic profiles; however, alterations in response to dietary sodium restriction (DSR) are completely unknown. The goal of this study was to explore changes in urine metabolites in response to DSR, as well as their association with previously reported improvements in vascular function with DSR. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using stored urine samples from a 10-week randomized placebo-controlled crossover study of DSR in 17 middle-aged/older adults (six men and 11 women; mean age 62±8 years) who had moderately elevated systolic BP (130-159 mmHg) and were otherwise healthy, a liquid chromatography/mass spectrometry-based analysis of 289 metabolites was performed. This study identified metabolites that were significantly altered between the typical (153±29 mmol/d) and low (70±29 mmol/d) sodium conditions, as well as their baseline (typical sodium) association with responsiveness to previously reported improvements in vascular endothelial function (brachial artery flow-mediated dilation) and large elastic artery stiffness (aortic pulse wave velocity). RESULTS: Of the 289 metabolites surveyed, 10 were significantly altered (nine were upregulated and one was downregulated) during the low sodium condition, and eight of these exceeded our prespecified clinically significant threshold of a >40% change. These metabolites were involved in biologic pathways broadly related to cardiovascular risk, nitric oxide production, oxidative stress, osmotic regulation, and metabolism. One metabolite, serine, was independently (positively) associated with previously reported improvements in the primary vascular outcome of brachial artery flow-mediated dilation. CONCLUSIONS: This proof-of-concept study provides the first evidence that DSR is a stimulus that induces significant changes in urinary metabolomic profiles. Moreover, serine was independently associated with corresponding changes in vascular endothelial function after DSR. Larger follow-up studies will be required to confirm and further elucidate the metabolic pathways that are altered in response to DSR.
Authors: Michael J Gibney; Marianne Walsh; Lorraine Brennan; Helen M Roche; Bruce German; Ben van Ommen Journal: Am J Clin Nutr Date: 2005-09 Impact factor: 7.045
Authors: Lawrence J Appel; Edward D Frohlich; John E Hall; Thomas A Pearson; Ralph L Sacco; Douglas R Seals; Frank M Sacks; Sidney C Smith; Dorothea K Vafiadis; Linda V Van Horn Journal: Circulation Date: 2011-01-13 Impact factor: 29.690
Authors: Vallabh O Shah; Raymond R Townsend; Harold I Feldman; Kirk L Pappan; Elizabeth Kensicki; David L Vander Jagt Journal: Clin J Am Soc Nephrol Date: 2012-12-06 Impact factor: 8.237
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Rafael Llorach; Mireia Urpi-Sarda; Olga Jauregui; Maria Monagas; Cristina Andres-Lacueva Journal: J Proteome Res Date: 2009-11 Impact factor: 4.466
Authors: Nikolaos Psychogios; David D Hau; Jun Peng; An Chi Guo; Rupasri Mandal; Souhaila Bouatra; Igor Sinelnikov; Ramanarayan Krishnamurthy; Roman Eisner; Bijaya Gautam; Nelson Young; Jianguo Xia; Craig Knox; Edison Dong; Paul Huang; Zsuzsanna Hollander; Theresa L Pedersen; Steven R Smith; Fiona Bamforth; Russ Greiner; Bruce McManus; John W Newman; Theodore Goodfriend; David S Wishart Journal: PLoS One Date: 2011-02-16 Impact factor: 3.240
Authors: Katherine J Overwyk; Zerleen S Quader; Joyce Maalouf; Marlana Bates; Jacqui Webster; Mary G George; Robert K Merritt; Mary E Cogswell Journal: Adv Nutr Date: 2020-09-01 Impact factor: 8.701
Authors: Paramita Pati; David J R Fulton; Zsolt Bagi; Feng Chen; Yusi Wang; Julia Kitchens; Lisa A Cassis; David W Stepp; R Daniel Rudic Journal: Hypertension Date: 2016-01-18 Impact factor: 10.190
Authors: Kelly Jin; Kenneth A Wilson; Jennifer N Beck; Christopher S Nelson; George W Brownridge; Benjamin R Harrison; Danijel Djukovic; Daniel Raftery; Rachel B Brem; Shiqing Yu; Mathias Drton; Ali Shojaie; Pankaj Kapahi; Daniel Promislow Journal: PLoS Genet Date: 2020-07-09 Impact factor: 5.917